The impact of a high-risk disease management program on perinatal outcomes in a managed care organization

Michelle R Hawkins1

  • 1Johns Hopkins HealthCare, LLC, USA.

The Case Manager
|August 3, 2005
PubMed

Insights

Technological advances improve survival for premature infants but increase healthcare costs. Preterm infants disproportionately consume newborn care expenditures, impacting healthcare organizations and society.

Area of Science:

  • Neonatal medicine
  • Healthcare economics

Background:

  • Medical technology advancements have improved survival rates for micropremature and very low birth-weight infants.
  • These technological improvements have led to a substantial increase in the financial burden on healthcare organizations.

Purpose of the Study:

  • To analyze the economic impact of increased survival rates for premature infants.
  • To highlight the financial strain on healthcare systems, third-party payers, and society.

Main Methods:

  • Analysis of national healthcare expenditure data for newborn care.
  • Examination of cost distribution based on infant gestational age and birth weight.

Main Results:

  • Annual US spending on newborn care totals $10.2 billion.
  • Infants born preterm, representing 10% of the population, consume 57% of these costs.
  • This indicates a disproportionate financial burden associated with preterm birth.

Conclusions:

  • Improved survival for premature infants, while a medical success, presents a significant economic challenge.
  • The high cost of caring for preterm infants impacts healthcare organizations, payers, and the broader economy.
  • Strategies are needed to manage the financial implications of neonatal intensive care.

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Nursing Diagnosis01:22

Nursing Diagnosis

Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...